Ray Joel G, Thompson Miles D, Vermeulen Marian J, Meier Chris, Wyatt Philip R, Wong Pui-Yuen, Summers Anne M, Farrell Sandra A, Cole David E C
Department of Medicine, St, Michael's Hospital, University of Toronto, 30 Bond Street, Toronto, Ontario, M5B 1W8, Canada.
BMC Pregnancy Childbirth. 2007 Sep 19;7:21. doi: 10.1186/1471-2393-7-21.
Maternal obesity and pre-pregnancy diabetes mellitus, features of the metabolic syndrome (MetSyn), are individual risk factors for neural tube defects (NTD). Whether they, in combination with additional features of MetSyn, alter this risk is not known. We evaluated the risk of NTD in association with maternal features of the MetSyn.
We used a population-based case-control study design in the province of Ontario, Canada. Cases and controls were derived from women who underwent antenatal maternal screening (MSS) at 15 to 20 weeks' gestation. There were 89 maternal cases with, and 434 controls without, an NTD-affected singleton pregnancy. Maternal features of MetSyn were defined by the presence of pre-pregnancy diabetes mellitus, body weight > or = 90th centile among controls, non-white ethnicity and/or serum highly sensitive C-reactive protein (hsCRP) > or = 75th centile of controls. Since hsCRP naturally increases in pregnancy, analyses were performed with, and without, the inclusion of hsCRP in the model.
Mean hsCRP concentrations were exceptionally high among study cases and controls (6.1 and 6.4 mg/L, respectively). When hsCRP was excluded from the model, the adjusted odds ratios for NTD were 1.9 (95% confidence interval 1.1-3.4) in the presence 1 feature of MetSyn, and 6.1 (1.1-32.9) in the presence of 2 or more features. When hsCRP was included, the respective risk estimates were attenuated to 1.6 (0.88-2.8) and 3.1 (1.2-8.3).
We found about 2-fold and 6-fold higher risk for NTD in the presence 1, and 2 or more features, of the metabolic syndrome, respectively. It is not clear whether this risk is altered by the presence of a high serum hsCRP concentration.
母体肥胖和孕前糖尿病是代谢综合征(MetSyn)的特征,也是神经管缺陷(NTD)的个体危险因素。它们与MetSyn的其他特征相结合是否会改变这种风险尚不清楚。我们评估了与MetSyn母体特征相关的NTD风险。
我们在加拿大安大略省采用基于人群的病例对照研究设计。病例和对照来自妊娠15至20周接受产前母体筛查(MSS)的女性。有89例受NTD影响的单胎妊娠的母体病例和434例无NTD的对照。MetSyn的母体特征通过孕前糖尿病的存在、体重在对照中>或=第90百分位数、非白人种族和/或血清高敏C反应蛋白(hsCRP)>或=对照的第75百分位数来定义。由于hsCRP在孕期自然升高,因此在模型中纳入和不纳入hsCRP进行了分析。
研究病例和对照中的平均hsCRP浓度异常高(分别为6.1和6.4mg/L)。当hsCRP从模型中排除时,存在1个MetSyn特征时NTD的调整比值比为1.9(95%置信区间1.1 - 3.4),存在2个或更多特征时为6.1(1.1 - 32.9)。当纳入hsCRP时,相应的风险估计值分别降至1.6(0.88 - 2.8)和3.1(1.2 - 8.3)。
我们发现,存在1个和2个或更多代谢综合征特征时,NTD风险分别高出约2倍和6倍。尚不清楚血清hsCRP浓度升高是否会改变这种风险。